| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 7 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 7 |
| 2 | TACROLIMUS OINTMENT 0.1% | 7 |
| 3 | ENALAPRIL | 5 |
| 4 | OMEPRAZOLE | 5 |
| 5 | OMEPRAZOLE MAGNESIUM | 5 |
| 6 | ADALIMUMAB | 3 |
| 7 | AZATHIOPRINE | 3 |
| 8 | CYCLOSPORINE | 3 |
| 9 | DEXAMETHASONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIKACIN SULFATE | 1 | 0.0006 |
| 1 | VANDETANIB | 1 | 0.0006 |
| 2 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 3 | INOTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 4 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 5 | VINORELBINE | 1 | 0.0001 |
| 6 | TRANEXAMIC ACID | 1 | 0.0001 |
| 7 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 9 | BLINATUMOMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 1 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | Bile Acid [EPC] | 2 | 0.0001 |
| 4 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Iron Chelator [EPC] | 1 | 0.0000 |